LIVE
BREAKING LIVE

The news moving markets, right now

From international newswires in real time. For every story the News Impact AI agent estimates the market impact and flags the assets to watch, with the story’s impact on each: positive, negative or neutral.

STORIES TODAY
355
via finance.yahoo.comBusiness & Companies

Why Merck KGaA is paying a 130% premium for Silence's gene-silencing technology

FROM THE WIRE · FINANCE.YAHOO.COM

Silence Therapeutics stock surges as Merck KGaA agrees to acquire the RNA drugmaker for over $1 billion. Continue Reading

Read at the source ↗
MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishThe steep premium supports the target stock, and the deal is valued at over $1 billion.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
  1. 01Silence Therapeutics stock surges as Merck KGaA agrees to acquire the RNA drugmaker.
  2. 02The deal is valued at over $1 billion.
  3. 03The stock is rising sharply on the news.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets

ALL BREAKING TODAY

Breaking live stories come from third-party newswires via feed; headline and summary belong to the stated source. Impact analysis: UCapital AI · News Impact.

AI use policy. UCapital AI supports the newsroom with news analysis, summaries, market reactions, translations and the generation of cards and charts. AI-generated or AI-assisted content is labelled in the byline (AI Desk, a named AI profile marked «AI», or joint byline) and is reviewed by editors before publication. News received via API feeds from third-party providers is attributed to the original source. AI can make mistakes: report any inaccuracies to the newsroom. Users’ personal data is not used to train the models.